EHA COVID-19 Webinar Series: Session 02 (COVID-19 & B-cell lymphoproliferative diseases)
From Reagan Sanders
Featuring an expert panel from China, Italy and Germany, this webinar is focused on the implications of treatments for B-cell lymphoproliferative diseases and the immune response to COVID-19 infection.
Topics covered include:
•Immune response in patients with B-cell lymphoproliferative diseases
•Therapies for B-cell lymphoproliferative diseases and the effect on immune response
•Risk of COVID-19 infection in patients B-cell lymphoproliferative diseases
Tune in and gain some interesting insights from 3 experts, who will be sharing their personal experiences and opinions on the local situations they see, relating to COVID-19 and B-cell Lymphoproliferative Diseases.
•Prof Jianfeng Zhou (Tongji hospital, Wuhan, Hubei, China)
•Prof Gianluca Gaidano (University of Eastern Piedmont, Novara, Italy)
•Prof Dr Hermann Einsele (University Hospital Würzburg, Würzburg, Germany)
Note: The content discussed during this webinar is based on the personal experiences & opinions of the speakers. No general, evidence-based guidance can be derived from this discussion.
This is the second session in a series of webinars looking at the care of hematology patients during the COVID-19 crisis. Visit https://ehaweb.org/covid-19/, for more information on our upcoming webinars.